Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chang

Showing results (131-140 of 5,345) with videos related to

Pageof 535
Sort By:
The Urologic Clinics of North America|April 2, 2013
Non-muscle invasive bladder cancerSam S Chang
Hematologic Pathology|January 1, 1993
Molecular pathology of acute promyelocytic leukemiaK S Chang
The Journal of Urology|March 27, 2025
Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of OncologySam S Chang
Chinese Medical Journal|September 1, 1977
Repair of defects of the eyelids and tarsal platesT S Chang
Applied Optics|February 20, 2010
Bragg electrostriction in optical waveguidesM S Chang
The Journal of Urology|May 9, 2019
Re: Characterization of Late Recurrence after Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer PatientsSam S Chang
The Journal of Urology|May 9, 2019
Re: Discrepancies in Staging, Treatment, and Delays to Treatment May Explain Disparities in Bladder Cancer Outcomes: An Update from the National Cancer Data Base (2004-2013)Sam S Chang
The Journal of Urology|January 24, 2018
Re: The Impact of Re-Transurethral Resection on Clinical Outcomes in a Large Multicentre Cohort of Patients with T1 High-Grade/Grade 3 Bladder Cancer Treated with bacille Calmette-GuérinSam S Chang
The Journal of Urology|January 24, 2018
Re: Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients with Advanced Urothelial Bladder CancerSam S Chang
The Journal of Urology|January 10, 2018
Re: Increasing Age is Not Associated with Toxicity Leading to Discontinuation of Treatment in Patients with Urothelial Non-Muscle-Invasive Bladder Cancer Randomised to Receive 3 Years of Maintenance bacille Calmette-Guérin: Results from European Organisation for Research and Treatment of Cancer Genito-Urinary Group Study 30911Sam S Chang
Pageof 535

Showing results (131-140 of 5,345) with videos related to

Sort By:
Pageof 535
The Urologic Clinics of North America|April 2, 2013
Non-muscle invasive bladder cancerSam S Chang
Hematologic Pathology|January 1, 1993
Molecular pathology of acute promyelocytic leukemiaK S Chang
The Journal of Urology|March 27, 2025
Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of OncologySam S Chang
Chinese Medical Journal|September 1, 1977
Repair of defects of the eyelids and tarsal platesT S Chang
Applied Optics|February 20, 2010
Bragg electrostriction in optical waveguidesM S Chang
The Journal of Urology|May 9, 2019
Re: Characterization of Late Recurrence after Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer PatientsSam S Chang
The Journal of Urology|May 9, 2019
Re: Discrepancies in Staging, Treatment, and Delays to Treatment May Explain Disparities in Bladder Cancer Outcomes: An Update from the National Cancer Data Base (2004-2013)Sam S Chang
The Journal of Urology|January 24, 2018
Re: The Impact of Re-Transurethral Resection on Clinical Outcomes in a Large Multicentre Cohort of Patients with T1 High-Grade/Grade 3 Bladder Cancer Treated with bacille Calmette-GuérinSam S Chang
The Journal of Urology|January 24, 2018
Re: Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients with Advanced Urothelial Bladder CancerSam S Chang
The Journal of Urology|January 10, 2018
Re: Increasing Age is Not Associated with Toxicity Leading to Discontinuation of Treatment in Patients with Urothelial Non-Muscle-Invasive Bladder Cancer Randomised to Receive 3 Years of Maintenance bacille Calmette-Guérin: Results from European Organisation for Research and Treatment of Cancer Genito-Urinary Group Study 30911Sam S Chang
Pageof 535